1 hr 14 min
PT233 - JR Rahn - LSD, ADHD, and Decriminalization Psychedelics Today
-
- Life Sciences
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD.
www.psychedelicstoday.com
In this episode, Joe interviews founder and CEO of MindMed, JR Rahn. They discuss decriminalization, the DEA, ADHD, Xanax, and MindMed’s goals: developing a trip-neutralizing drug and studying microdosing LSD for adult ADHD.
www.psychedelicstoday.com
1 hr 14 min